Buy & Sell Tenet Healthcare Corporation (THC) – Tenet Healthcare Corporation Price Today
Aura AI Summary
Key Stats
- $16.72BMarket Cap
- HealthSector
- -27.65%3M Drawdown
- $26.96BEnterprise Value
- -Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 3 daysTypical Hold Time
Tenet Healthcare Corporation (THC) is currently valued at a market capitalization of $16.72B, with an enterprise value of $26.96B. Over the past 52 weeks, Tenet Healthcare Corporation has traded between a low of $148.38 and a high of $244.8, highlighting its annual price range. Over the past three months, Tenet Healthcare Corporation has recorded a drawdown of -27.65%, reflecting recent price volatility. On average, investors hold Tenet Healthcare Corporation for approximately 3 days, indicating typical investor behavior on the platform.
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Most Recent News
Investors invited to join Cross Country Healthcare fraud investigation by Schall Law Firm
The Schall Law Firm is investigating Cross Country Healthcare, Inc. for potential securities law violations, including false or misleading statements and failure to disclose important information. Investors who suffered losses are encouraged to parti...
Cohen & Steers updates components in its Global and International Realty Majors Indexes effective May 15, 2026
Cohen & Steers announced changes to its Global Realty Majors Portfolio Index and International Realty Majors Portfolio Index, effective after market close on May 15, 2026. The updates include adding Azrieli Group Ltd. and removing LEG Immobilien AG f...
Atkore director sells shares after mixed Q2 results with earnings beat but lower profit year-over-year.
Atkore Inc. director James Wilbert W Jr. sold 3,299 shares at $73.61 each following the company's Q2 earnings report. The company reported earnings of $1.23 per share, beating estimates but down from $2.04 per share a year ago, while revenue grew to ...